Shariat SF - Search Results

1

Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.

Roscigno M, Shariat SF, Freschi M, Margulis V, Karakiewizc P, Suardi N, Remzi M, Zigeuner R, Bolenz C, Kikuchi E, Weizer A, Bensalah K, Sagalowsky A, Koppie TM, Raman J, Fernández M, Ströbel P, Kabbani W, Langner C, Wheat J, Guo CC, Kassouf W, Haitel A, Wood CG, Montorsi F. Roscigno M, et al. Among authors: shariat sf. Urology. 2009 Nov;74(5):1070-4. doi: 10.1016/j.urology.2009.04.084. Urology. 2009. PMID: 19883824

2

Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?

Djavan B, Shariat S, Ghawidel K, Güven-Marberger K, Remzi M, Kovarik J, Hoerl WH, Marberger M. Djavan B, et al. Urology. 1999 Jun;53(6):1169-74. doi: 10.1016/s0090-4295(99)00010-2. Urology. 1999. PMID: 10367847 Clinical Trial.

3

Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.

Shariat SF, Weizer AZ, Green A, Laucirica R, Frolov A, Wheeler TM, Lerner SP. Shariat SF, et al. Urology. 2000 Nov 1;56(5):735-40. doi: 10.1016/s0090-4295(00)00756-1. Urology. 2000. PMID: 11068290

4

E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.

Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA JR, Wheeler TM, Lerner SP. Byrne RR, et al. Among authors: shariat sf. J Urol. 2001 May;165(5):1473-9. J Urol. 2001. PMID: 11342899

5

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.

Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Shariat SF, et al. Urology. 2001 Dec;58(6):1008-15. doi: 10.1016/s0090-4295(01)01405-4. Urology. 2001. PMID: 11744478

6

Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.

Andrews B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, Lerner SP. Andrews B, et al. Among authors: shariat sf. J Urol. 2002 Mar;167(3):1475-81. J Urol. 2002. PMID: 11832773

7

Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer.

Shariat SF, Kim J, Nguyen C, Wheeler TM, Lerner SP, Slawin KM. Shariat SF, et al. Urology. 2003 Feb;61(2):359-64. doi: 10.1016/s0090-4295(02)02253-7. Urology. 2003. PMID: 12597948

8

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.

Shariat SF, Monoski MA, Andrews B, Wheeler TM, Lerner SP, Slawin KM. Shariat SF, et al. Urology. 2003 May;61(5):1053-8. doi: 10.1016/s0090-4295(02)02522-0. Urology. 2003. PMID: 12736046

9

The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer.

Shariat SF, Casella R, Monoski MA, Sulser T, Gasser TC, Lerner SP. Shariat SF, et al. J Urol. 2003 Dec;170(6 Pt 1):2244-7. doi: 10.1097/01.ju.0000090965.71697.37. J Urol. 2003. PMID: 14634389

10

Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy.

Matsumoto K, Shariat SF, Casella R, Wheeler TM, Slawin KM, Lerner SP. Matsumoto K, et al. Among authors: shariat sf. J Urol. 2003 Dec;170(6 Pt 1):2248-52. doi: 10.1097/01.ju.0000094189.93805.17. J Urol. 2003. PMID: 14634390

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,936 results

Search Page

Filters